Skip to main content
Livermore
Livermore
ZHEN

Poseida Therapeutics, Inc.

PSTXDelisted Jan 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001661460

Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Poseida Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PSTX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6271+9
Shares28.9M27.9M−1.05M (−3.6%)
Value$276.3M$279.3M+$3.05M (+1.1%)

New holders (15)

Institutions that held Poseida Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PSTX in Q2 2021
InstitutionSharesValue% of portfolio
J. Goldman & Co LP202,501$2.03M0.13%
Balyasny Asset Management LLC80,202$804.0K0.00%
Pendal Group Limited48,561$487.0K0.00%
Parametric Portfolio Associates LLC36,961$370.0K0.00%
Ergoteles LLC28,300$284.0K0.01%
Virtus ETF Advisers LLC24,287$243.0K0.10%
Federated Hermes, Inc.16,656$167.0K0.00%
ExodusPoint Capital Management, LP15,200$152.0K0.00%
Boothbay Fund Management, LLC13,304$133.0K0.01%
Pinz Capital Management, LP11,200$112.0K0.03%
Invesco Ltd.10,675$107.0K0.00%
Jane Street Group, LLC10,110$101.0K0.00%
Rockefeller Capital Management L.P.1,250$12.0K0.00%
Nisa Investment Advisors, LLC300$3.00K0.00%
Simplex Trading, LLC81$00.00%

Sold out (6)

Institutions that held Poseida Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of PSTX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Susquehanna International Group, LLP48,451$463.0K
Algert Global LLC19,410$185.0K
MetLife Investment Management14,683$140.2K
Metropolitan Life Insurance Co9,154$87.4K
STRS Ohio3,400$32.0K
Bank of Montreal1,033$9.00K